- Home
- BNTC
as 08-01-2025 4:00pm EST
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | HAYWARD |
| Market Cap: | 335.5M | IPO Year: | N/A |
| Target Price: | $26.00 | AVG Volume (30 days): | 82.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.47 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.05 - $17.15 | Next Earning Date: | 09-25-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Benitec Biopharma Inc. News
BNTC Breaking Stock News: Dive into BNTC Ticker-Specific Updates for Smart Investing
Zacks
a month ago
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
Zacks
2 months ago
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?
Zacks
2 months ago
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year?
Zacks
2 months ago
Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet
Zacks
2 months ago
Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?
GlobeNewswire
3 months ago
Benitec Biopharma Releases Third Quarter 2025 Financial Results
Zacks
3 months ago
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks
3 months ago
Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?
Compare BNTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BNTC Benitec Biopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.